Fundamental Research · 2022 · 19 citations · 195 references
MedicineImmunologyOncologyImmunotherapyTumor ImmunologyTumor MicroenvironmentCancer ImmunotherapyCancer VaccinesImmune Checkpoint InhibitorsImmune Checkpoint RegulationTumor Immune MicroenvironmentTumor-associated AntigensCancer Immunotherapy ResistanceImmunosuppressive MicroenvironmentPhase Iii Clinical TrialsPhase Iii Oncology TrialsTumor Antigen VaccinesTumor Microenvironment ResistanceTumor Microenvironment-mediated ResistanceTumor-immune Crosstalk
Immunotherapy has rejuvenated cancer therapy, especially after anti-PD-(L)1 came onto the scene. Among the many therapeutic options, therapeutic cancer vaccines are one of the most essential players. Although great progress has been made in research on tumor antigen vaccines, few phase III trials have shown clinical benefits. One of the reasons lies in obstruction from the tumor microenvironment (TME). Meanwhile, the therapeutic cancer vaccine reshapes the TME in an ambivalent way, leading to immune stimulation or immune escape. In this review, we summarize recent progress on the interaction between therapeutic cancer vaccines and the TME. With respect to vaccine resistance, innate immunosuppressive TME components and acquired resistance caused by vaccination are both involved. Understanding the underlying mechanism of this crosstalk provides insight into the treatment of cancer by directly targeting the TME or synergizing with other therapeutics.
195
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
F. Stephen Hodi, Steven O’Day, David F. McDermott et al. · New England Journal of Medicine · 2010 · 15.2K citations · Full text
Hallmarks of Cancer: New Dimensions
Cancer Discovery · 2022 · 9.1K citations · Full text
Medicine, Cancer Biology, Oncology +17
Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
Philip W. Kantoff, Celestia S. Higano, Neal D. Shore et al. · New England Journal of Medicine · 2010 · 5.5K citations · Full text
THE DISTRIBUTION OF SECONDARY GROWTHS IN CANCER OF THE BREAST.
Stephen A. Paget · The Lancet · 1889 · 5.1K citations
Medicine, Cancer Biology, Oncology +12
Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer
Uğur Şahin, Evelyna Derhovanessian, Matthias Miller et al. · Nature · 2017 · 2.5K citations
Medicine, Immunology, Oncology +14